active substance: drotaverine;
1 tablet contains drotaverine hydrochloride 40 mg excipients: magnesium stearate, talc, povidone, corn starch, lactose.
Spasms of smooth muscles associated with diseases of the biliary tract: cholecystolithiasis, cholangiolithiasis, cholecystitis, pericholecystitis, cholangitis, papillitis. Spasms of smooth muscles in diseases of the urinary tract: nephrolithiasis, urethrolithiasis, pyelitis, cystitis, tenesmus of the bladder.
As an auxiliary treatment: for spasms of smooth muscles of the gastrointestinal tract: gastric ulcer and duodenal ulcer, gastritis, cardio and / or pylorospasm, enteritis, colitis, spastic colitis with constipation and irritable bowel syndrome, accompanied by flatulence; tension headaches; with gynecological diseases: dysmenorrhea.
Hypersensitivity to drotaverine or to any component of the drug. Severe hepatic, renal, or heart failure (small cardiac output syndrome).
Adults: the recommended dose of the drug is 120-240 mg per day in 2-3 doses. Children: the use of drotaverine in children has not been studied in clinical trials; if the use of drotaverine is necessary, then: for children 6-12 years old, the maximum daily dose is 80 mg (divided into 2 doses) for children over 12 years old, the maximum daily dose is 160 mg (divided into 2-4 doses)
Store in original packaging at temperatures below 25 ° C.